Global Animal Model Market To Flourish At The Rate Of 6% During Forecast Period

The global animal model market was worth around $1.4 billion in 2021 and is predicted to grow to around $2.5 billion by 2028 at a CAGR rate of 6% over the forecast period.

Animals and humans have similar biological and physiological structures. The genotype resemblance with humans is also notable when it comes to animals. They are used commonly in biomedical research to develop new treatment methods for chronic diseases.

The efficacy of vaccinations and medications is determined through animal model studies.

They are used in all stages of testing including prognosis, diagnosis, treatment, and study of diseases. Histological studies along with the development of drugs are accomplished with the help of animal model testing. Pharmaceutical companies and academic institutes use these models on a frequent basis for various applications. The immune response of humans and animals have been similar which offers perfect leverage for animal model testing.

These tests also determine whether the medications administered are safe or not. The trials will determine whether a particular treatment method can be implemented. It is exclusively leveraged in all fields like research, production, and quality control.

The global animal model market has had significant growth during pandemic times. The production and testing of vaccines took a lot of prominence during that time and animal model testing became more popular. The researchers and drug developers detected positive and negative results using animal model testing to develop the vaccinations. The efficacy rate was also determined with the help of this method. The adverse impact of vaccines was also discovered through animal model experimentation. Hence the therapeutic treatment for SARS-COV-2 was devised through the leverage of animal model testing thereby amplifying its market rate to a large extent.

Drug developments and vaccinations have become the trend of recent times because of the emergence of new diseases and chronic illnesses. Scientists and researchers are coming up with new treatment methods and effective medications to cure diseases. Hence animal model testing has become more prominent thereby increasing its leverage.

Researchers across the world are also focusing on bringing precision to the tests to perfect the cure and diagnosis of patients. All the metabolic activities of humans match with that of animals and that adds to the benefit of physicians to modify their medications according to the results. This contributes to revenue growth substantially.

The prevalence of the geriatric population and the influx of chronic illness in older patients induce the need for accurate animal model testing. The experiments made on the animals detect the effect of the diseases on the patients and also the right treatment procedures needed for the cure.

The vaccination programs across the world have hiked the demand for animal model studies. The efficacy rate of these vaccinations and medicines is determined through this method which spikes up the demand and market expansion.

On the other hand, the cost associated with the studies and the regulations required for these tests impedes the market growth. The ethical concerns regarding these tests also restrict the revenue growth exclusively.

The global animal model market is fragmented into animal type, technology, application, end-user, and region. Animal types consist of pigs, cats, and mice. The applications are classified as research, development, production, and quality control. The end-users include research institutes, educational institutes, pharmaceutical institutes, and contract research organizations

North America is the region that is regarded as the major contributor to global animal model market growth. The increasing support and investment made by the government in these regions for the improvisations of healthcare sectors boost the market growth. Many funded reform policies by the authorities also offer an opportunity for market expansion. Asia-Pacific region trails as the second-largest sharer of the global market due to the absence of any restrictions on implementing these testing methods. There is also an abundance of geriatric population in this region which instigates an improved treatment procedure. This factor hikes up the demand for animal model studies to a large extent.

The key players in the global animal model market are Horizon Discovery Group, Charles River Laborotories International, Inc., Transposagen Biopharmaceuticals, Inc., Trans Genic Inc, Envigo CRS SA, Eurofins Scientific SE, Crown Bioscience, INC., The Jackson Laboratory, Genoway SA

Recent Developments:

• In April 2021, Horizon Discovery Group created and developed IgM antibodies and obtained a license for the commercial agreement of animal model testing.
• In October 2020, Mammoth Bioscience secured a new license for the generation of CHO cells using mice testing procedures.

Browse the full “Animal Model Market By Animal Type (Pigs, Cats, and Mice), By Technology (Microinjection and Embryonic Stem Cell Injection), By Application (Research, Development, Production, and Quality Control), By End-User (Research Institutes, Educational Institutes, Pharmaceutical Companies, and Contract Research Organizations), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/animal-model-market

The global animal model market is segmented as follows:

By Animal Type

• Pigs
• Cats
• Mice

By Application

• Research
• Development
• Production
• Quality Control

By End-Users

• Research Institutes
• Educational Institutes
• Pharmaceutical Organizations
• Contract Research Organizations

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com